Search research articles
Contact Us
Filters
Showing results (31-40 of 56) with videos related to
Page
of 6
Sort By:
Journal of the National Cancer Institute
|
December 27, 2025
Differential censoring in overall survival in phase 3 oncology clinical trials
Eric J Hsu, Alexander D Sherry, Timothy A Lin, et al.
JAMA Network Open
|
March 9, 2022
Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural Mesothelioma
Tomer Meirson, Francesca Pentimalli, Francesco Cerza, et al.
Oncotarget
|
May 19, 2018
Targeting invadopodia-mediated breast cancer metastasis by using ABL kinase inhibitors
Tomer Meirson, Alessandro Genna, Nikola Lukic, et al.
JAMA Network Open
|
January 22, 2025
Reanalysis of Urothelial Cancer Chemoimmunotherapy Trials With Differential Censoring
Tomer Meirson, Jonathan Ofer, Noa Zimhony-Nissim, et al.
Journal of Translational Medicine
|
December 13, 2022
Analysis of new treatments proposed for malignant pleural mesothelioma raises concerns about the conduction of clinical trials in oncology
Tomer Meirson, Valerio Nardone, Francesca Pentimalli, et al.
Oncotarget
|
September 18, 2018
Tumor cell density regulates matrix metalloproteinases for enhanced migration
Hasini Jayatilaka, Fatima G Umanzor, Vishwesh Shah, et al.
Journal for Immunotherapy of Cancer
|
May 15, 2021
Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy
Abraham Nissani, Shaked Lev-Ari, Tomer Meirson, et al.
Cells
|
November 8, 2019
Hepatitis C Virus Enhances the Invasiveness of Hepatocellular Carcinoma via EGFR-Mediated Invadopodia Formation and Activation
Liat Ninio, Abraham Nissani, Tomer Meirson, et al.
JAMA Network Open
|
March 28, 2024
Differential Treatment Effects of Subgroup Analyses in Phase 3 Oncology Trials From 2004 to 2020
Alexander D Sherry, Andrew W Hahn, Zachary R McCaw, et al.
Microbiology Spectrum
|
October 31, 2022
HCV Infection Increases the Expression of ACE2 Receptor, Leading to Enhanced Entry of Both HCV and SARS-CoV-2 into Hepatocytes and a Coinfection State
Tom Domovitz, Samer Ayoub, Michal Werbner, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 56) with videos related to
Sort By:
Page
of 6
Journal of the National Cancer Institute
|
December 27, 2025
Differential censoring in overall survival in phase 3 oncology clinical trials
Eric J Hsu, Alexander D Sherry, Timothy A Lin, et al.
JAMA Network Open
|
March 9, 2022
Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural Mesothelioma
Tomer Meirson, Francesca Pentimalli, Francesco Cerza, et al.
Oncotarget
|
May 19, 2018
Targeting invadopodia-mediated breast cancer metastasis by using ABL kinase inhibitors
Tomer Meirson, Alessandro Genna, Nikola Lukic, et al.
JAMA Network Open
|
January 22, 2025
Reanalysis of Urothelial Cancer Chemoimmunotherapy Trials With Differential Censoring
Tomer Meirson, Jonathan Ofer, Noa Zimhony-Nissim, et al.
Journal of Translational Medicine
|
December 13, 2022
Analysis of new treatments proposed for malignant pleural mesothelioma raises concerns about the conduction of clinical trials in oncology
Tomer Meirson, Valerio Nardone, Francesca Pentimalli, et al.
Oncotarget
|
September 18, 2018
Tumor cell density regulates matrix metalloproteinases for enhanced migration
Hasini Jayatilaka, Fatima G Umanzor, Vishwesh Shah, et al.
Journal for Immunotherapy of Cancer
|
May 15, 2021
Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy
Abraham Nissani, Shaked Lev-Ari, Tomer Meirson, et al.
Cells
|
November 8, 2019
Hepatitis C Virus Enhances the Invasiveness of Hepatocellular Carcinoma via EGFR-Mediated Invadopodia Formation and Activation
Liat Ninio, Abraham Nissani, Tomer Meirson, et al.
JAMA Network Open
|
March 28, 2024
Differential Treatment Effects of Subgroup Analyses in Phase 3 Oncology Trials From 2004 to 2020
Alexander D Sherry, Andrew W Hahn, Zachary R McCaw, et al.
Microbiology Spectrum
|
October 31, 2022
HCV Infection Increases the Expression of ACE2 Receptor, Leading to Enhanced Entry of Both HCV and SARS-CoV-2 into Hepatocytes and a Coinfection State
Tom Domovitz, Samer Ayoub, Michal Werbner, et al.
Page
of 6